BAJAJ BROKING
Dishman Carbogen’s France-based Carbogen Amcis SAS receives GMP compliance certification for its Saint-Beauzire site from ANSM, strengthening its position in the global pharmaceutical sector.
Dishman Carbogen’s France-based arm, Carbogen Amcis SAS, has secured the Good Manufacturing Practice (GMP) compliance certificate for its Saint-Beauzire site. The certification was granted by the National Agency for the Safety of Medicine and Health Products (ANSM), the French regulatory authority. The GMP certificate validates the quality and safety standards of the site, strengthening Carbogen Amcis SAS’s position in the global pharmaceutical industry.
The Saint-Beauzire site plays a crucial role in the production of active pharmaceutical ingredients (APIs) and highly potent drugs. With this certification, Carbogen Amcis SAS ensures that its manufacturing processes adhere to stringent European quality standards. This achievement is expected to boost investor confidence and positively impact the Dishman Carbogen share price.
Also read: Adani’s KCL Forms JV with Praneetha Ecocables to Manufacture Cables and Wires
Dishman Carbogen’s France-based Carbogen Amcis SAS secures GMP compliance certificate.
Certification granted by ANSM for the Saint-Beauzire site.
Ensures quality and safety of API and highly potent drug production.
Enhances Dishman Carbogen’s global pharmaceutical credibility.
Positive outlook for Dishman Carbogen share price expected.
Also read: Setback for Vodafone Idea, Bharti Airtel as AGR Waiver No Longer Considered
The GMP compliance certification from ANSM reinforces Carbogen Amcis SAS’s commitment to maintaining the highest standards in pharmaceutical manufacturing. The Saint-Beauzire site, a key facility in the production of APIs and complex drug substances, now meets European regulatory requirements for quality and safety.
With the pharmaceutical sector placing heightened emphasis on quality assurance, this certification significantly strengthens Dishman Carbogen’s reputation as a reliable contract manufacturing partner. The positive development is likely to attract new business opportunities and strategic collaborations, boosting the Dishman Carbogen share price in the process.
Site Name | Certification Authority | Certification Type | Date Granted |
Saint-Beauzire | ANSM | GMP Compliance | 19 March 2025 |
The certification news is expected to have a favourable impact on the Dishman Carbogen share price, as it underscores the company’s commitment to quality and regulatory compliance. Investors are likely to view this achievement positively, given the heightened focus on quality standards in the pharmaceutical industry.
Moreover, the certification aligns with the company’s strategic goal of expanding its presence in regulated markets. With this recognition, Dishman Carbogen is poised to enhance its credibility as a leading global player in the API and drug development segment.
Dishman Carbogen’s successful acquisition of the GMP compliance certificate for its Saint-Beauzire site marks a significant milestone in its journey towards maintaining the highest quality standards. The certification not only strengthens the company’s market presence but also signals a potential positive impact on the Dishman Carbogen share price, reflecting increased investor confidence and business potential.
Also read: Vedanta Targets Zero Debt in 3-4 Years, Plans $3.5 Billion Reduction by 2027
Do you have a trading account app or demat account app?
You can open an account with Bajaj Broking in minutes.
Download the Bajaj Broking app now from Play Store or App Store.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer
Share this article:
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading